Review Reports
- Moonef Alotaibi 1,2,
- Felix Caffier 3 and
- Philipp P. Caffier 1,4,*
- et al.
Reviewer 1: Chaitanya Gadepalli Reviewer 2: Anonymous
Round 1
Reviewer 1 Report
Comments and Suggestions for AuthorsDear Editor,
Many thanks for allowing me to read this paper. This paper is of good clinical value and I feel will benefit readers at various levels . I have some comments which you and authors may find useful
The authors present a thorough review of pre‑ and post‑operative voice quality assessment in laryngeal leukoplakia, incorporating subjective, perceptual, objective, and videoendoscopic measures.
- While it is well established that appropriately performed phonosurgical interventions improve voice outcomes, it is unclear what novel contribution this study adds to the existing literature. But this is still an interesting read.
- The authors demonstrate postoperative improvements in voice quality within a heterogeneous cohort, which supports the effectiveness of their surgical approach.
- VEM has been included as one of the objective assessment tools; this method was originally introduced as a novel technique by the authors in 2018.
- At least twelve of the cited references are previous publications by the same group, reflecting both their substantial experience in this field and a notable degree of self‑citation.
- Voice quality assessment practices vary considerably across centres. As this paper will be read internationally, it would be helpful to clarify the rationale for selecting VHI‑9 instead of VHI‑10 or 30, and GRB rather than GRBAS. The discussion explains the use of VEM, but similar justification for the other tools would benefit readers at all levels.
- The term “VHIs” is unclear—does this refer to the 30‑item questionnaire? This should be explicitly stated. The manuscript notes that VHI‑9 is a 9‑item instrument, but the distinction between VHI, VHIs, and VHI‑9 needs clarification.
- Please include the VHI‑9 questionnaire in the appendix with appropriate references.
- A brief explanation of DSI would be valuable for readers who may be less familiar with these measures. I have noted that the authors have explained VEM.
- Section 2.2: Please specify which surgical techniques were used to preserve voice function. Were ELS Type 1 or Type 2 approaches employed? Subepithelial resections correspond to ELS Type 1.
- Page 4, line 157: Please clarify the rationale for overnight admission, as the described procedure appears to be a minimally invasive excision of a leukoplakic lesion.
- Section 2.3 (Examiners’ Tools and Standards): How was voice recording standardised?
– What was the mouth‑to‑microphone distance and how was background noise controlled?
– Did the phoniatricians assess recorded samples, or did they evaluate patients live in clinic? - The cohort includes 34 unilateral and 10 bilateral cases. What were the voice outcomes specifically for patients undergoing bilateral vocal fold surgery? Apologies if this information is present but was not easily identifiable.
- Line 229: Nearly one quarter of cases (24%, n=13) exhibited preserved phonatory mobility and regular mucosal wave propagation. This suggests that the surgical technique was precise enough to maintain normal mucosal wave function in a significant subset of patients.
- Section 3.2: Please clarify why some patients underwent laser surgery while others received cold‑steel excision.
- Line 321: All parameters except DSI and F0max showed slight average improvements. Is there an explanation for this pattern?
- Table 2: Please clarify the distinction between VHI and VHIs. Are these not both measures of self‑perceived voice handicap? Should these be labelled VHI‑9 and VHI‑30 (or VHI‑10)?
- Figure 4: The interquartile range for DSI appears wider postoperatively. This should be addressed in the discussion, as it may have clinical implications.
- Figure 4: Please expand all abbreviations, including GRB and VHI.
- The limitations section is clearly articulated.
Author Response
Please see the attachment.
Author Response File:
Author Response.pdf
Reviewer 2 Report
Comments and Suggestions for AuthorsThe topic is clinically relevant and the dataset is carefully gathered with thoughtful multidimensional voice assessment. However, there are some issues that need to be addressed.
Major comments
1. Unit of analysis & statistical independence: The manuscript blends per‑patient and per‑lesion counts without making the analytic unit explicit, and some labels appear incorrect. Example: Table 1 is labeled Resection type per patient but totals 30 + 18 + 6 = 54, suggesting per‑lesion, not per‑patient. Likewise, postoperative phonatory mobility sums to 54, again suggesting lesion‑level rather than patient‑level tallies. Please correct the labels and ensure consistent counting throughout. If some analyses are lesion‑level while others are patient‑level, the current statistical approach may violate independence (bilateral lesions within a single patient are not independent). Re‑specify the unit of analysis for each endpoint and re‑analyze accordingly.
You start with 714 adults and end with 44 analyzed; reasons for exclusion are listed narratively but the numbers per exclusion step are not shown. This raises the risk of selection bias and makes reproducibility difficult. Add a flow diagram (e.g., STROBE‑style) detailing: screened (714) → excluded with reasons and counts (resolution, minimal lesion, suspected invasive cancer, non‑leukoplakia mimickers, declined surgery, incomplete data, lost to follow‑up, etc.) → included (n=44).
In the Abstract you state that phonosurgical method, histopathology, and age did not significantly affect voice outcomes, while younger age was associated with greater VEM gains (the latter implies an age effect).
You report 6/44 (14%) recurrences over a mean of 16 months (range 3–46), but means are not ideal for time‑to‑event data with variable follow‑up.
5. All postoperative voice measures were obtained at three months only; please justify this time point and, if possible, provide information on longer‑term voice outcomes (even descriptively) for those with extended follow‑up. Discuss clinical significance beyond statistical significance.
Minor comments
1. Table 1 labeling & structure
Split per‑patient and per‑lesion summaries into separate tables or subpanels; ensure headers match counts.
2. Abstract: Replace post vs. pre with post vs preoperative for clarity.
3. Limitations: You provide a good list; please add explicit acknowledgement of selection bias (44/714), single‑center, and lack of adjustment for multiple testing.
Author Response
Please see the attachment.
Author Response File:
Author Response.pdf